Manipal Health Enterprises Shares List at Over 10% Premium on NSE

Manipal Health Enterprises made a strong debut on the Indian stock market on Wednesday, August 5, 2026. The stock listed at ₹652 on the NSE, a 10.51% premium over its IPO issue price of ₹590. On the BSE, the shares opened at ₹655, representing an 11.02% premium, reflecting healthy investor interest following the company's public issue.

Manipal Health Enterprises IPO Listing Details

Manipal Health Enterprises launched its ₹9,275.22 crore IPO, which remained open for subscription from July 29 to July 31, 2026.

The public issue received a healthy response from investors, with the IPO being subscribed 4.92 times by the close of bidding.

First-Day Trading Performance

Listing Price: Manipal Health Enterprises share price debuted at ₹652 on the NSE, delivering a 10.51% listing gain over its IPO issue price of ₹590.

On the BSE, the stock opened at ₹655, translating into an 11.02% premium over the issue price, indicating positive investor sentiment towards India's leading healthcare provider.

Growth Drivers and Challenges

Growth Drivers

Largest Private Hospital Network by Bed Capacity: Operates 49 hospitals with 13,037 licensed beds across 14 states and union territories, making it India's largest private hospital network by bed capacity.

Strong Presence in High-End Specialties: Offers advanced tertiary and quaternary healthcare services across cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences (CONGO-R), which contributed 64.3% of gross inpatient revenue in FY26.

Large Patient Base: Served approximately 7.63 million patients during FY26, supported by a medical workforce of 11,064 doctors.

Expansion Through Acquisitions: Strengthened its footprint through acquisitions of AMRI Hospitals, Medica Synergie, and the Sahyadri Group, while planning to add around 2,426 licensed beds by 2030.

Challenges

Capital-Intensive Business: Hospital expansion and infrastructure development require significant capital investment.

Regulatory Environment: Operations are subject to evolving healthcare regulations and compliance requirements.

Integration Risk: Successful integration of acquired hospital networks is essential to achieving operational efficiencies.

Competitive Healthcare Sector: Faces intense competition from other large hospital chains and regional healthcare providers.

Utilisation of IPO Proceeds

The company plans to utilise the net proceeds from the fresh issue for:

• Repayment or prepayment of certain outstanding borrowings and accrued interest of its material subsidiary, Manipal Hospitals Private Limited.
• Acquisition of a minority stake in its step-down subsidiary, Sahyadri Hospitals Private Limited.
• Meeting general corporate purposes.

Business Overview

Manipal Health Enterprises is one of India's leading multispecialty hospital operators, managing a network of 49 hospitals with 13,037 licensed beds across 14 states and union territories as of March 31, 2026. It is the country's largest private hospital network by bed capacity and the second-largest by number of hospitals.

The company provides advanced healthcare services across major specialties, including cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences, serving approximately 7.63 million patients in FY26 with the support of 11,064 doctors.

Backed by a strong healthcare network, strategic acquisitions, and ambitious expansion plans, Manipal Health Enterprises entered the stock market with a healthy double-digit listing premium, reflecting investor confidence in its leadership position and long-term growth prospects in India's healthcare sector.